Neil Stahl, SVP Research and Development S at REGENERON PHARMACEUTICALS INC (REGN), sold 5,307 shares at $409.71 ($2.2M) on 2014-11-24, disclosed to the SEC on 2014-11-24.
Open-market sale of $2.2M REGN by SVP Research and Development S. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $415.16 | 3,107 | $1.3M | 58.9% |
| 2 | $409.71 | 1,787 | $732K | 33.4% |
| 3 | $410.10 | 413 | $169K | 7.7% |
| Total | $412.93 avg | 5,307 | $2.2M | 100% |
| Filing → |
| REGN | SELL | 2023-08-23 | $19.6M | — | Filing → |
| REGN | SELL | 2022-08-08 | $28.4M | — | Filing → |
| REGN | SELL | 2021-05-18 | $18.2M | — | Filing → |